Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Sanofi nails phase 3 LUNA landing, sparking race to regulators
Sanofi plans to file for approval of a “multi-indication blockbuster” that it predicts could contribute to more than 10 billion euros of launch sales.
Nick Paul Taylor
Apr 23, 2024 2:23am
Sponsored
Cloud-Based Technology Supports Complex Supply Chains
Apr 22, 2024 8:00am
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Apr 23, 2024 10:43am
BenevolentAI lays off 30% of staff, exits US site in latest cuts
Apr 23, 2024 7:35am
Daily aspirin use may limit spread of colorectal tumor cells
Apr 23, 2024 3:50am
New immunotherapy drug design ups survival in mice with cancer
Apr 23, 2024 3:40am
Research News
Charles River launches program for animal testing alternatives
Apr 18, 2024 6:00am
Europe leads in cystic fibrosis trials, North America for AML
Apr 16, 2024 5:00pm
SelSym hopes to control bleeding via squishy synthetic platelets
Apr 16, 2024 4:30am
AACR: KRAS inhibitors pop in preclinical data debuts
Apr 11, 2024 4:30am
See More Research News